Skip to main content
. Author manuscript; available in PMC: 2009 Aug 13.
Published in final edited form as: J Neuroimmunol. 2008 Jun 10;199(1-2):126–132. doi: 10.1016/j.jneuroim.2008.04.031

Table 6.

VH4-VH2 Repertoire Bias, MRI Lesion Load, Oligoclonal Banding and Conversion to Definite MS

Subject High Risk MRIA Oligoclonal Bands VH4 Bias in CD138 Plasma Cells VH2 Bias in CD138 Plasma Cells VH4 Bias in CD19 B Cells VH2 Bias in CD19 B Cells MS Risk Based on VH4-VH2 Bias Definite MSB Time to Diagnosis
ON03-3 + + + + Clinical 3 mo
ON03-5 + + + + + Clinical 2 mo
ON04-7 + + + + + Clinical 5 mo
ON04-8 + + + N.A.C N.A. + Clinical 5 mo
ON05-2 + + + + Clinical 3 mo
CIS03-1 + + + + + MRI 3 mo
CIS04-3 + + + N.A. N.A. + Clinical 6 mo

ON03-1 + +
ON03-4 N.A. N.A.
ON04-10 + N.A. N.A.
A

High risk MRI is defined as 2 or more T2-weighted lesions white matter lesions on brain imaging

B

MS was diagnosed by either a new clinical event (Clinical) or a new MRI lesion (MRI). MRI diagnosis was made by the International Criteria (Polman et al., 2005).

C

N.A. - Not amplified

Abbreviations: mo, months